• 1
    Jacob F., Polzin DJ, Osborne CA, et al. Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure. J Am Vet Med Assoc 2005;226: 393400.
  • 2
    Grauer GF, Greco DS, Getzy DM, et al. Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. J Vet Intern Med 2000;14: 526533.
  • 3
    Grodecki KM, Gains MJ, Baumal R., et al. Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor. J Comp Pathol 1997;117: 209225.
  • 4
    Maschio G., Alberti D., Janin G., et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996;334: 939945.
  • 5
    Ruggenenti P., Perna A., Gherardi G., et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999;354: 359364.
  • 6
    Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo It-aliano di Studi Epidemiologici in Nefrologia). Lancet1997;349: 18571863.
  • 7
    Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329: 14561462.
  • 8
    Remuzzi G., Bertani T.. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339: 14481456.
  • 9
    Keane WF. Proteinuria: Its clinical importance and role in progressive renal disease. Am J Kidney Dis 2000;35(Suppl 1): S97S105.
  • 10
    Zoja C., Benigni A., Remuzzi G.. Cellular responses to protein overload: Key event in renal disease progression. Curr Opin Nephrol Hypertens 2004;13: 3137.
  • 11
    DiBartola SP, Chew DJ, Jacobs G.. Quantitative urinalysis including 24–hour protein excretion in the dog. J Am Anim Hosp Assoc 1980;16: 537546.
  • 12
    Center SA, Wilkinson E., Smith CA, et al. 24-Hour urine protein/creatinine ratio in dogs with protein-losing nephropathies. J Am Vet Med Assoc 1985;187: 820824.
  • 13
    Moore FM, Brum SL, Brown L.. Urine protein determination in dogs and cats: Comparison of dipstick and sulfasalicylic acid procedures. Vet Clin Pathol 1991;20: 9597.
  • 14
    Brown SA, Finco DR, Brown CA, et al. Evaluation of the effects of inhibition of angiotensin converting enzyme with enalapril in dogs with induced chronic renal insufficiency. Am J Vet Res 2003;64: 321327.
  • 15
    Brown SA, Brown CA, Crowell WA, et al. Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency. J Lab Clin Med 1998;131: 447455.
  • 16
    Brown SA, Brown CA, Crowell WA, et al. Effects of dietary polyunsaturated fatty acid supplementation in early renal insufficiency in dogs. J Lab Clin Med 2000;135: 275286.
  • 17
    McGowan J., Chesney PJ, Crossley KB, LaForce FM. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America. J Infect Dis 1992;165: 113.
  • 18
    Polzin DJ. Treating feline renal failure: An evidence-based approach. American College of Veterinary Internal Medicine 20th Forum, Dallas, TX, May 29-June 1, 2002.